Texas Yale Capital Corp’s Xtant Medical Holdings XTNT Stock Holding History

Texas Yale Capital Corp’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-833	Closed	-$6K	–	450
2017 Q4	$6K	Hold	833	–	–	﹤0.01%	438
2017 Q3	$7K	Hold	833	–	–	﹤0.01%	442
2017 Q2	$7K	Hold	833	–	–	﹤0.01%	447
2017 Q1	$6K	Hold	833	–	–	﹤0.01%	442
2016 Q4	$6K	Buy	+833	New	+$7.19K	﹤0.01%	426
2016 Q3	–	Sell	-833	Closed	-$19K	–	447
2016 Q2	$19K	Hold	833	–	–	﹤0.01%	448
2016 Q1	$27K	Hold	833	–	–	﹤0.01%	445
2015 Q4	$28K	Buy	+833	New	+$29.3K	﹤0.01%	441
2015 Q3	–	Sell	-833	Closed	-$35K	–	491
2015 Q2	$35K	Buy	+833	New	+$42.4K	﹤0.01%	473
2015 Q1	–	Sell	-833	Closed	-$30K	–	484
2014 Q4	$30K	Hold	833	–	–	﹤0.01%	459
2014 Q3	$45K	Buy	+833	New	+$55.4K	﹤0.01%	427

Other funds holding XTNT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Texas Yale Capital Corp's XTNT Position: Q1 2018 in Review

Texas Yale Capital Corp sold out of Xtant Medical Holdings (XTNT) in Q1 2018, closing a stake of 833 shares — an estimated $6K sold.

Texas Yale Capital Corp first reported a position in XTNT in Q3 2014 and held it in 11 quarters. The position peaked at $45K in Q3 2014. 14 funds tracked by Wall St. Rank hold XTNT as of Q1 2018.

Texas Yale Capital Corp reported no remaining Xtant Medical Holdings position as of Q1 2018 after selling out during the quarter.
Texas Yale Capital Corp sold 833 Xtant Medical Holdings shares in Q1 2018, an estimated $6K.
Texas Yale Capital Corp first reported a position in Xtant Medical Holdings in Q3 2014 and held it in 11 quarters.
Texas Yale Capital Corp's Xtant Medical Holdings position peaked at $45K in Q3 2014.
14 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2018.

Based on Texas Yale Capital Corp's 13F filing for Q1 2018, filed 3 May 2018.